Comparison of telbivudine and entecavir on the change of off- treatment eGFR after 3 years of treatment in non-cirrhotic chronic hepatitis B patients

BACKGROUND: The change of estimated glomerular filtration rate (eGFR) with off-treatment nucleos(t)ide analogues (NA) in chronic hepatitis B patients (CHB) is unclear. This study is aimed to evaluate the off-treatment eGFR after 3 years of therapy with telbivudine (LdT) or entecavir (ETV) and to ass...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Yang-Sheng, Shih, Shou-Chuan, Wang, Horng-Yuan, Lin, Ching-Chung, Chang, Chen-Wang, Chen, Ming-Jen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5282840/
https://www.ncbi.nlm.nih.gov/pubmed/28137301
http://dx.doi.org/10.1186/s12876-017-0582-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5282840/
https://www.ncbi.nlm.nih.gov/pubmed/28137301
http://dx.doi.org/10.1186/s12876-017-0582-0

Ejemplares similares